Best Potassium Channel Blocker for gait disorders, neurologic
The 2 Potassium Channel Blocker options we list for gait disorders, neurologic are all Dalfampridine— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for gait disorders, neurologic or the full Potassium Channel Blocker class. Not medical advice — always consult a professional.
Quick answer: Of the 2 potassium channel blocker drugs we rate for gait disorders, neurologic, all are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for gait disorders, neurologic; the right choice depends on your situation, so confirm it with your prescriber.
These are all Dalfampridinein different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 2 potassium channel blocker products
ampyra
PrescriptionFDA-sourced
Ampyra (Dalfampridine) is a potassium channel blocker used to treat Multiple Sclerosis, Neurologic Gait Disorders.
Pharmacy pays
~$11.78 /30
dalfampridine
PrescriptionFDA-sourced
Dalfampridine is a potassium channel blocker used to treat Multiple Sclerosis, Neurologic Gait Disorders.
Pharmacy pays
~$11.78 /30
Frequently asked
- What is the best potassium channel blocker for gait disorders, neurologic?
- The Potassium Channel Blocker options we list for gait disorders, neurologic are all Dalfampridine — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which potassium channel blocker drugs treat gait disorders, neurologic?
- pharmaranks lists 2 Potassium Channel Blocker products used for gait disorders, neurologic, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.